A platform for research: civil engineering, architecture and urbanism
Evaluation of functionalized porous titanium implants for enhancing angiogenesis in vitro
Implant constructs supporting angiogenesis are favorable for treating critically-sized bone defects, as ingrowth of capillaries towards the center of large defects is often insufficient. Consequently, the insufficient nutritional supply of these regions leads to impaired bone healing. Implants with specially designed angiogenic supporting geometry and functionalized with proangiogenic cytokines can enhance angiogenesis. In this study, Vascular Endothelial Growth Factor (VEGF) and High Mobility Group Box 1 (HMGB1) were used for incorporation into poly-ε-caprolactone (PCL)-coated porous titanium implants. Bioactivity of released factors and influence on angiogenesis of functionalized implants were evaluated using a migration assay and angiogenesis assays. Both implants released angiogenic factors, inducing migration of endothelial cells. Also, VEGF-functionalized PCL-coated titanium implants enhanced angiogenesis in vitro. Both factors were rapidly released in high doses from the implant coating during the first 72 h. ; DFG/299/11-1
Evaluation of functionalized porous titanium implants for enhancing angiogenesis in vitro
Implant constructs supporting angiogenesis are favorable for treating critically-sized bone defects, as ingrowth of capillaries towards the center of large defects is often insufficient. Consequently, the insufficient nutritional supply of these regions leads to impaired bone healing. Implants with specially designed angiogenic supporting geometry and functionalized with proangiogenic cytokines can enhance angiogenesis. In this study, Vascular Endothelial Growth Factor (VEGF) and High Mobility Group Box 1 (HMGB1) were used for incorporation into poly-ε-caprolactone (PCL)-coated porous titanium implants. Bioactivity of released factors and influence on angiogenesis of functionalized implants were evaluated using a migration assay and angiogenesis assays. Both implants released angiogenic factors, inducing migration of endothelial cells. Also, VEGF-functionalized PCL-coated titanium implants enhanced angiogenesis in vitro. Both factors were rapidly released in high doses from the implant coating during the first 72 h. ; DFG/299/11-1
Evaluation of functionalized porous titanium implants for enhancing angiogenesis in vitro
Roland, Laura (author) / Backhaus, Samantha (author) / Grau, Michael (author) / Matena, Julia (author) / Teske, Michael (author) / Beyerbach, Martin (author) / Escobar, Hugo Murua (author) / Haferkamp, Heinz (author) / Gellrich, Nils-Claudius (author) / Nolte, Ingo (author)
2016-01-01
Materials 9 (2016), Nr. 4
Article (Journal)
Electronic Resource
English
In Vivo Evaluation of Porous Titanium Implants with Biomimetic Coating
British Library Online Contents | 2009
|Fabrication of porous titanium implants with biomechanical compatibility
British Library Online Contents | 2009
|Gelatin functionalised porous titanium alloy implants for orthopaedic applications
British Library Online Contents | 2014
|Osseointegration evaluation of plasma nitrided titanium implants
British Library Online Contents | 2009
|Evaluation in vitro and in vivo of biomimetic hydroxyapatite coated on titanium dental implants
British Library Online Contents | 2004
|